Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)
Background: High alpha-fetoprotein (AFP) expressions (>400 ng/mL) are associated with poor oncological characteristics for hepatocellular carcinoma (HCC). However, prognosis after liver resection for high-AFP HCC is poorly studied. To investigate long-term recurrence and survival after hepatectomy for high-AFP HCC, and to identify the predictive value of postoperative incomplete biomarker response (IBR) on overall survival (OS) and recurrence-free survival (RFS). Methods: Patients undergoing curative resection for high-AFP HCC were analyzed. According to the decline magnitude of serum AFP as measured at first follow-up (4 similar to 6 weeks after surgery), all patients were divided into the complete biomarker response (CBR) and IBR groups. Characteristics, recurrence, and survival rates were compared. Univariate and Multivariate Cox-regression analyses were performed to identify independent predictors associated with poorer OS and RFS after liver resection for high-AFP HCC. Results: Among 549 patients, the overall and early recurrence rates in patients with IBR were significantly higher than patients with CBR (97.8%vs.56.4%, and 92.5%vs.33.3%, both P<0.001). On multivariate analysis, postoperative IBR was the strongest risk factor with the highest hazard ratio in predicting poor OS (HR 2.97; 95% CI 2.49 similar to 3.45; P<0.001) and RFS (HR 4.29; 95% CI 3.31 similar to 5.55; P<0.001). Conclusion: Postoperative biomarker response of serum AFP can be used in predicting recurrence and survival for high-AFP HCC patients. Once postoperative IBR was identified at first follow-up, subsequent enhanced recurrence surveillance and available treatments against recurrence should actively be considered.
基金:
National Natural Science Foundation of China [81702334, 81672699, 81972726]; Shanghai Sailing Program [17YF1424900]
第一作者单位:[1]Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Pancreat & Minimal Invas Surg, Peoples Hosp, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China[2]Hangzhou Med Coll, Sch Clin Med, Hangzhou, Zhejiang, Peoples R China
通讯作者:
通讯机构:[1]Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Pancreat & Minimal Invas Surg, Peoples Hosp, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China[2]Hangzhou Med Coll, Sch Clin Med, Hangzhou, Zhejiang, Peoples R China[3]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Navy Med Univ, Shanghai, Peoples R China[8]Hangzhou Med Coll, Key Lab Tumor Mol Diag & Individualized Med Zheji, Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Liang Lei,Wang Ming-Da,Zhang Yao-Ming,et al.Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)[J].JOURNAL OF HEPATOCELLULAR CARCINOMA.2021,8:103-118.doi:10.2147/JHC.S289840.
APA:
Liang, Lei,Wang, Ming-Da,Zhang, Yao-Ming,Zhang, Wan-Guang,Zhang, Cheng-Wu...&Yang, Tian.(2021).Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).JOURNAL OF HEPATOCELLULAR CARCINOMA,8,
MLA:
Liang, Lei,et al."Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)".JOURNAL OF HEPATOCELLULAR CARCINOMA 8.(2021):103-118